Pulsed-Field Ablation for Atrial Fibrillation: Tissue Selectivity, Learning Curves and Unanswered Durability Questions

Abstract

Catheter ablation for atrial fibrillation has relied for two decades on thermal energy -- radiofrequency heating or
cryoballoon freezing -- to destroy the cardiac tissue responsible for triggering or sustaining the arrhythmia, with
esophageal injury, phrenic nerve palsy, and pulmonary vein stenosis as recognized, if uncommon, costs of that thermal
indiscriminateness. Pulsed-field ablation uses very short high-voltage electric pulses instead, a mechanism itsproponents argue is preferentially toxic to myocardial tissue and largely spares the structures thermal energy can injure. Four studies published in close succession now let this claim, and the technology's broader adoption, be assessed with real data rather than mechanism alone.